Estrogen receptor beta, Novus Biologicals, NB200-303

Novus Biologicals NB200-303 · Estrogen receptor beta · mAb · Mouse
Applications: Western Blot, Immunostaining, IP, ChIP
2.23
(Overall rating from 1 review) #7 of 14 targeting Estrogen receptor beta
Overall Rating
2.23
From 1 review · #7 of 14 for Estrogen receptor beta

Information about this antibody

Target
Estrogen receptor beta
Alt. Targets
ERbeta, NR3A2
Vendor
Novus Biologicals
Catalog No
NB200-303
Application
Western Blot, Immunostaining, IP, ChIP
Clonality
mAb
Origin
Mouse
Reactivity
Human
Conjugation
N/A
Product Link
N/A

Vendor notes

No vendor notes available for this antibody.

pAbmAbs Average Ratings

ℹ
Immunostaining
2.25
Overall
2.23

User Reviews (1)

Review of: Estrogen receptor beta, Novus Biologicals, NB200-303 by Cecilia Williams, KTH Royal Institute of Technology, Sweden

Reviewed: August 2, 2017

Andersson et al. Nature Communications 2017 describe the validation of thirteen commercial and academic antibodies raised against estrogen receptor beta (ERbeta).
The present antibody failed in the IHC validation step (1:225 and 1:300 dilutions) since it recognized both ERbeta positive cells and ERbeta negative cells.
See link to full article above.

Ratings from this reviewer
Immunostaining

Comments

Cecilia WilliamsKTH Royal Institute of Technology, Sweden14 reviews
Thumbs up 0 useful
Thumbs down 0 not useful

Submit Your Review of Estrogen receptor beta, Novus Biologicals, NB200-303

Please log in to submit a review.